← Back to Search

Dietary Supplement

Dietary supplement for Premenstrual Syndrome

N/A
Waitlist Available
Led By Susanne Mitschke
Research Sponsored by Your Super, INC.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This is an open-label observational single-group clinical trial to study the efficacy of a commercially available dietary supplement and its effect on common PMS and menstrual symptoms, as well as health-related biomarkers.

Eligible Conditions
  • Premenstrual Syndrome
  • Menstrual Cramps
  • Menstrual Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in perceived discomfort associated with menstruation
Secondary outcome measures
Change in blood biomarkers: C-reactive protein
Changes in saliva cortisol levels

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dietary supplementExperimental Treatment1 Intervention
Dietary supplement: Moon Balance
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Moon Balance
2022
N/A
~40

Find a Location

Who is running the clinical trial?

CitruslabsIndustry Sponsor
68 Previous Clinical Trials
3,807 Total Patients Enrolled
5 Trials studying Premenstrual Syndrome
270 Patients Enrolled for Premenstrual Syndrome
Your Super, INC.Lead Sponsor
1 Previous Clinical Trials
38 Total Patients Enrolled
Susanne MitschkePrincipal InvestigatorCitruslabs
6 Previous Clinical Trials
343 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~12 spots leftby Apr 2025